Top Markets
Coin of the day
Midatech Pharma plc Midatech Pharma plc

Midatech Pharma plc

MTPH
Classement en actions #42756
Midatech Pharma plc operates as a pharmaceutical company specializing in drug... Midatech Pharma plc operates as a pharmaceutical company specializing in drug delivery technologies. Its core activities revolve around the research and development of therapeutic compounds, with operations spanning the United Kingdom, broader Europe, and global markets. Currently, its pipeline includes several key developments: MTX110, an innovative direct-delivery therapy targeting diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immunosuppressant designed for topical use against psoriasis; MTD211, a sustained-release version of brexpiprazole intended for managing schizophrenia and as an add-on therapy for major depressive disorder; and MTD219, a prolonged-action formulation of tacrolimus aimed at reducing the likelihood of organ transplant rejection. Beyond its specific drug candidates, Midatech Pharma provides advanced drug delivery platforms. These include Q-Sphera, a microtechnology based on polymer microspheres that enables drugs to be released over extended periods; MidaSolve, a nanotechnology employing oligosaccharides to enhance drug solubility, allowing direct and localized administration into tumors; and MidaCore, a gold nanoparticle system engineered to precisely deliver chemotherapeutic or immunotherapeutic agents to disease sites. Established in 2000, the company maintains its headquarters in Cardiff, United Kingdom.
Prix de l'action
$0.05309195
Dernière synchronisation: 2023-04-24
Capitalisation boursière
$164.43
Changement (1 jour)
0.46%
Changement (1 an)
0.00%
Pays
GB
Échange Midatech Pharma plc (MTPH)

Catégorie

EPS pour Midatech Pharma plc (MTPH)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Midatech Pharma plc, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Midatech Pharma plc de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR